According to a recent LinkedIn post from Hazel Health, an independent 2023 evaluation by Clemson University of the company’s H.E.A.R.T. teletherapy program reportedly found that 75% of participating students experienced a clinically significant reduction in depression and anxiety. The post also cites partner school districts reporting improved attendance, with some students gaining up to 11 additional days in school.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights the potential for school-based teletherapy to drive both mental health improvements and measurable educational outcomes such as attendance. For investors, these data points may signal growing validation of Hazel Health’s outcomes-focused model, which could strengthen its value proposition with school districts, support contract renewals or expansions, and enhance its competitive positioning in the K–12 telehealth and behavioral health markets.
The emphasis on consistent gains across demographic groups suggests a focus on equitable access and outcomes, a theme that may resonate with public sector buyers and grant-funded initiatives. If such results are replicated at scale and viewed as credible by administrators and payers, Hazel Health could benefit from increased demand for integrated mental health services in schools, potentially supporting long-term revenue visibility in an environment where student wellness is an increasing policy and budget priority.